The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment…

To explore the effect of erdosteine on COPD exacerbations, health-related quality of life (HRQoL), and subjectively assessed COPD severity

Fixed drug eruption and anaphylaxis induced concurrently by erdosteine: a cas…

Erdosteine is used as a mucolytic agent and has a low incidence of adverse drug reactions, most of which are gastrointestinal and mild. Moreover, drug antigens rarely induce multiple simultaneous immunologic reactions. Only one previous case report has demonstrated hypersensitivity reaction induced by erdosteine. Here, we report a case of fixed drug eruption and anaphylaxis, which were concurre…

Erdosteine in children and adults with bronchiectasis (BETTER trial): study p…

Bronchiectasis is a worldwide chronic lung disorder where exacerbations are common. It affects people of all ages, but especially Indigenous populations in high-income nations. Despite being a major contributor to chronic lung disease, there are no licensed therapies for bronchiectasis and there remain relatively few randomised controlled trials (RCTs) conducted in children and adults. Our RCT …

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent

Erdosteine is a drug approved for the treatment of acute and chronic pulmonary diseases, originally developed as a mucolytic agent. It belongs to the thiol-based family of drugs that are known to also possess potentially important antioxidant and anti-inflammatory properties, and exhibit antibacterial activity against a variety of medically important bacterial species. Erdosteine is a prodru…

Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent

Erdosteine is a drug approved for the treatment of acute and chronic pulmonary diseases, originally developed as a mucolytic agent. It belongs to the thiol-based family of drugs that are known to also possess potentially important antioxidant and anti-inflammatory properties, and exhibit antibacterial activity against a variety of medically important bacterial species. Erdosteine is a prodru…

Chronic Cough and Gastroesophageal Reflux in Children: CHEST Guideline and E…

Whether gastroesophageal reflux (GER) or GER disease (GERD) causes chronic cough in children is controversial. Using the Population, Intervention, Comparison, Outcome (PICO) format, we undertook four systematic reviews. For children with chronic cough (> 4-weeks duration) and without underlying lung disease: (1) who do not have gastrointestinal GER symptoms, should empirical treatment for GERD …

A practical guide to transthoracic ultrasound

Transthoracic ultrasonography is a well-established, yet underutilised imaging modality in respiratory medicine. It allows for real-time and mobile assessment of thoracic disorders and can potentially augment the physical examination of the chest. Moreover, ultrasonography-assisted interventions can be performed by a single clinician without sedation and with minimal monitoring, even outside o…

Tuberculous Lymphadenitis

Lymphadenitis is the most common extrapulmonary manifestation of tuberculosis. It remains both diagnostic and therapeutic challenge because it mimics other pathologic processes and yields inconsistent physical and laboratory findings. Diagnosis is difficult often requiring biopsy. A thorough history and physical examination, staining for acid-fast bacilli, fine-needle aspiration and PCR are hel…

Tuberculous Lymphadenitis: Early Diagnosis and Intervention

Tuberculosis (TB) is reported to be one of the most widespread systemic bacterial infectious diseases frequently triggered by Mycobacterium TB. It is anticipated to have a prevalence of approximately 8 million individuals each year, and 3 million individuals die of complications related with the ailment. We present a case of a 5-year-old female patient with a painless swelling in her left sub…

Diagnosis dan Tatalaksana Pleuritis Tuberkulosis

Edition

-

ISBN/ISSN

-

Collation

-

Series Title

-

Call Number

-